Market revenue in 2023 | USD 269.4 million |
Market revenue in 2030 | USD 430.4 million |
Growth rate | 6.9% (CAGR from 2023 to 2030) |
Largest segment | Anti-infective |
Fastest growing segment | Endocrinology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 26.76% in 2023. Horizon Databook has segmented the South Korea home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
According to World Bank Group, the country’s population aged 65 & above accounted for nearly 15.1% of the total population in 2019. In addition, according to Cable News Network, the country’s population aged above 65 is estimated to be around 23.4% by 2030. Rapidly growing geriatric population is anticipated to increase the demand for long-term and home care services, thereby fueling the market growth. Furthermore, in 2018, the Korean government announced a plan to expand the scope of home services for senior residents, which is expected to be realized by 2025.
Such supportive government initiatives are anticipated to propel the market growth. Presence of innovative local companies such as Meinntech Co., Ltd. is also anticipated to contribute to the market growth. For instance, Meinntech’s Any fusion model is a combination product of syringe and infusion pump, thus leveraging the benefits of both systems in one model.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea home infusion therapy market , including forecasts for subscribers. This country databook contains high-level insights into South Korea home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account